|
|
|
Cogentin advertisement, 1972. Hospital & Community Psychiatry, Vol. 23, No. 5. when extrapyramidal symptoms upset phenothiazine therapy COGENTIN® (benztropine mesylate MSD) helps keep productive therapy from becoming counterproductive * Helps relieve rigidity and tremor * Provides long duration of action * Frequently permits continuation of the phenothiazine without change of dosage Contraindications: Children under three years of age; use cautiously in older children. Warnings: Safe use in pregnancy not established. May impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. For more detailed information, consult your MSD representative or see the Direction Circular. Merck Sharp & Dohme, Division of Merck & Co., Inc. West Point, Pa. 19486 |